Fusion Looking To Enter Cranial Surgery Sealant Market With Proceed Gel
This article was originally published in The Gray Sheet
Executive Summary
Fusion Medical sees a $35 mil. market opportunity for the cranial indication of the firm's Proceed hemostatic sealant, based on a projected per-kit price of $140 and more than 240,000 cranial procedures performed worldwide annually.